| Laura Conway, RN, CPSN | |
|
2802 Great Northern Loop, Missoula, MT 59808-1738 | |
| (406) 728-3811 | |
| (406) 721-9141 |
| Full Name | Laura Conway |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Plastic Surgery |
| Location | 2802 Great Northern Loop, Missoula, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164576146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0121X | Registered Nurse - Plastic Surgery | RN18431 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Laura Conway, RN, CPSN 2802 Great Northern Loop, Missoula, MT 59808-1738 Ph: (406) 728-3811 | Laura Conway, RN, CPSN 2802 Great Northern Loop, Missoula, MT 59808-1738 Ph: (406) 728-3811 |
News Archive
VR entails a lot of potential for the future research in ophthalmology and beyond in any scientific field that uses three-dimensional data.
Could a change in diet be beneficial to people with autoimmune diseases such as lupus? A Yale-led team of researchers have revealed how a dietary intervention can help prevent the development of this autoimmune disease in susceptible mice.
Aire-19, the new ventilation system for COVID-19 patients, developed by researchers from the Polytechnic University of Valencia, the Institute of Biomechanics (IBV) and Technological Institute AIDIMME, has received the authorization of the Spanish Agency for Medicines and Healthcare Products (AEMPS) for its use in clinical research, which will take place for 12 months in Valencia's Hospital Clínico.
Researchers have found links between an individual's genetics and their response to treatment with chemotherapy. The findings, by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues, show how a genetic variant, located in the SOD2 gene, may affect how a person responds to the chemotherapy drug cyclophosphamide. Cyclophosphamide is used in the treatment of breast and other cancers.
Myriad Genetics announced today that it has initiated enrollment in a Phase 3 human clinical trial of its lead therapeutic candidate, Flurizan (MPC-7869), in patients with Alzheimer's disease.
› Verified 8 days ago
Bianca Villalobos, RN BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 830 W Central Ave, Missoula, MT 59801 Phone: 406-829-9515 | |
Monica Marie Brooke, APRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 900 N Orange St Ste 103, Missoula, MT 59802 Phone: 406-329-5776 | |
Ms. Gina Carol Digiusto, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 634 Eddy Ave, Missoula, MT 59812 Phone: 406-243-2790 | |
Jeanne Marie Biebinger, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1624 Wyoming St, Missoula, MT 59801 Phone: 406-363-9028 Fax: 406-363-9028 | |
Ms. Shannon Dunlap King, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 634 Eddy Ave, Missoula, MT 59812 Phone: 406-243-4330 | |
Carolyn Louise Thornton, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1624 Wyoming St, Missoula, MT 59801 Phone: 406-363-9028 Fax: 406-363-9028 |